NCT03995654
Research of Burden of Interstititial Lung Diseases in Turkey No drug interventions Not Available Not Available unknown_status NCT03438032
Identifying Unique Pathogenic Macrophages in Systemic Sclerosis-ILD No drug interventions Not Available Not Available completed NCT05227443
Effects of Exercise Training on Respiratory Performance in Patients With Fibrosing Interstitial Lung Diseases No drug interventions supportive_care Not Available completed NCT04527354
Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia treatment 2 completed NCT06465654
Automated Oxygen Titration During Walking in Patients With Lung Fibrosis (OXYWILD) No drug interventions treatment Not Available recruiting NCT06075836
AI Assisted Detection of Chest X-Rays No drug interventions Not Available Not Available active_not_recruiting NCT06416163
FIBRotic Interstitial Lung Disease With Nocturnal hypOXaemia and EXercise Induced desaTuRAtion No drug interventions Not Available Not Available not_yet_recruiting NCT05681962
Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy No drug interventions Not Available Not Available recruiting NCT05382572
Pulmonary Fibrosis Foundation Community Registry No drug interventions Not Available Not Available recruiting NCT01570764
Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease treatment 3 completed NCT06189820
Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases No drug interventions diagnostic 2 recruiting NCT05572346
Digital App for Telerehabilitation in Respiratory Diseases No drug interventions Not Available Not Available recruiting NCT05191381
Immune Modulation by Exosomes in COVID-19 No drug interventions Not Available Not Available recruiting NCT05648734
Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary Fibrosis Not Available Not Available completed NCT04274257
A Study of the Efficacy and Safety of Rituximab in Participants With Systemic Sclerosis treatment 2 / 3 completed NCT04990531
Low-field Magnetic Resonance Imaging of Pediatric COVID-19 No drug interventions diagnostic Not Available unknown_status NCT05516550
Study to Assess Efficacy and Safety of Treamid for Patients With Reduced Exercise Tolerance After COVID-19 treatment 2 / 3 unknown_status NCT00359736
Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis treatment 2 completed NCT05310669
Inspiratory Effort Assessed Through Nasal Pressure Measurement in Patients With Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available not_yet_recruiting NCT06527612
The Effect of Exercise Training on Quality of Life and Disease Progression in Fibrosing Interstitial Lung Patients No drug interventions treatment Not Available recruiting NCT05087017
Influence of Regular Physical Activity on Sleep in Patients With COPD and Idiopathic Lung Fibrosis No drug interventions Not Available Not Available unknown_status NCT06528418
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath No drug interventions Not Available Not Available recruiting NCT06644144
P4O2 ILD Extension No drug interventions Not Available Not Available not_yet_recruiting NCT04564183
Advancing Prevention of Pulmonary Fibrosis No drug interventions Not Available Not Available active_not_recruiting NCT05299333
Comparison of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Post Covid Fibrosis No drug interventions treatment Not Available recruiting NCT05392881
Interstitial Lung Disease Research Unit Biobank No drug interventions Not Available Not Available recruiting NCT04482595
BIO 300 Oral Suspension in Previously Hospitalized Long COVID Patients treatment 2 active_not_recruiting NCT05883293
Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary Fibrosis No drug interventions treatment 0 recruiting NCT05330312
Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF No drug interventions treatment Not Available completed NCT05387239
Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19 No drug interventions treatment 2 suspended NCT06122233
REBUILD-SM Study for People With Interstitial Lung Disease (ILD) No drug interventions supportive_care Not Available recruiting NCT06615492
Routine vs On-demand ECMO for Lung Transplantation No drug interventions treatment Not Available not_yet_recruiting NCT04864990
Dyspnea and Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available recruiting NCT00504621
The Influence of Personality on Pulmonary Fibrosis and Sarcoidosis No drug interventions Not Available Not Available completed NCT01615484
Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability No drug interventions treatment Not Available completed NCT01442779
Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis treatment 2 completed NCT00517933
Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis treatment 3 completed NCT01917877
Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab treatment 2 recruiting NCT01335477
Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II treatment 3 completed NCT03535545
Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients No drug interventions diagnostic 1 recruiting NCT04432545
Infusion of Allogeneic Mesenchymal Stem Cells in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement No drug interventions Not Available Not Available available NCT04304898
An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology No drug interventions Not Available Not Available recruiting NCT00084305
Analysis of Specimens From Individuals With Pulmonary Fibrosis No drug interventions Not Available Not Available recruiting NCT04253405
RENOVATE Fibrosis:HFNC Versus NIPPV in Acute Respiratory Failure in Patients With Pulmonary Fibrosis No drug interventions treatment Not Available terminated NCT06532071
Advanced Imaging for Pulmonary Fibrosis No drug interventions diagnostic 2 not_yet_recruiting NCT03103178
Spanish Version of the KBILD Questionnaire No drug interventions Not Available Not Available unknown_status NCT01501578
Pulmonary Fibrosis and Telomerase Mutation Study No drug interventions Not Available Not Available completed NCT06304207
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease No drug interventions prevention Not Available recruiting NCT00366509
Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases No drug interventions Not Available Not Available completed NCT01417156
Safety and PK Study of BIBF 1120 in Japanese Patients With IPF: Follow up Study From 1199.31(NCT01136174) treatment 2 completed NCT05981885
68Ga-FAPI PET/CT to Detect Ongoing Fibroblast Activity in Post-acute COVID-19 No drug interventions Not Available Not Available completed NCT00690885
Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis treatment 2 terminated NCT04964115
Post Acute Sequelae of COVID-19 No drug interventions Not Available Not Available active_not_recruiting NCT04680832
Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD No drug interventions diagnostic Not Available recruiting NCT00052052
An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT05356052
Expanded Access for Patients With Pulmonary Hypertension Associated With Pulmonary Fibrosis No drug interventions Not Available Not Available available NCT05331300
A Study to Evaluate the Safety, Preliminary Efficacy, and Pharmacokinetic Properties of LASN01 in Healthy Subjects and in Patients With Pulmonary Fibrosis or Thyroid Eye Disease No drug interventions treatment 1 / 2 active_not_recruiting NCT04416100
Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) No drug interventions Not Available Not Available unknown_status NCT03242759
Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan Not Available Not Available completed NCT04409275
LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION No drug interventions Not Available Not Available unknown_status NCT06179342
Multiple Breath Washout as a Method for Diagnosing Lung Diseases No drug interventions Not Available Not Available completed NCT00001618
Segmental Bronchoalveolar Lavage No drug interventions Not Available Not Available completed NCT05174741
Pulmonary Rehabilitation in Non-chronic Obstructive Pulmonary Disease Patients. No drug interventions treatment Not Available not_yet_recruiting NCT04638517
The TELO-SCOPE Study: Attenuating Telomere Attrition With Danazol. Is There Scope to Dramatically Improve Health Outcomes for Adults and Children With Pulmonary Fibrosis treatment 2 recruiting NCT03462524
Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology No drug interventions Not Available Not Available completed NCT00639496
Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF) treatment 3 completed NCT00076635
An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF treatment 3 terminated NCT05859763
99mTc-HFAPI SPECT/CT in Pulmonary Fibrosis No drug interventions diagnostic Not Available recruiting NCT04805086
The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 No drug interventions treatment 1 / 2 unknown_status NCT01653730
Comparative Study of 3 Portable Oxygen Concentrators During a 6-minute Walk Test in Patients With Chronic Lung Disease No drug interventions supportive_care Not Available completed NCT00131274
Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study educational_counseling_training 2 / 3 completed NCT00001876
Lung Disease Associated With Rheumatoid Arthritis No drug interventions Not Available Not Available completed NCT06423560
Pulmonary Fibrosis After Severe COVID-19 Pneumonia No drug interventions Not Available Not Available completed NCT06399094
Frequency-time Analysis of Pathological Lung Sounds: Detection and Quantification of Pathological Sounds in Patients With Cystic Fibrosis, Pulmonary Fibrosis or COPD (Chronic Obstructive Pulmonary Disease) No drug interventions Not Available Not Available not_yet_recruiting NCT00650091
Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF treatment 3 completed NCT04517162
Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients treatment 1 / 2 unknown_status NCT05180162
Imaging of Pathologic Fibrosis Using 68Ga-FAP-2286 No drug interventions diagnostic 1 recruiting NCT01961362
Supplemental Oxygen in Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT02668029
Effect of Ambulatory Oxygen on the Walking Test in Patients With Pulmonary Fibrosis supportive_care 2 completed NCT04930289
Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs No drug interventions Not Available Not Available enrolling_by_invitation NCT06160440
The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects. No drug interventions treatment 1 completed NCT00515567
Explanted Lung Tissues With Pulmonary Fibrosis No drug interventions Not Available Not Available recruiting NCT00786201
A Study to Evaluate the Safety and Effectiveness of CNTO 888 Administered Intravenously (IV) in Participants With Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT02603068
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis treatment 2 withdrawn NCT05676112
Safety of Nintedanib in Real World in China Not Available Not Available withdrawn NCT04308681
A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis treatment 2 completed NCT00005295
Idiopathic Pulmonary Fibrosis: a Case-control Study No drug interventions Not Available Not Available terminated NCT00896155
Trial of Concurrent Versus Sequential Tamoxifen With Radiotherapy in Breast Cancer Patients treatment 3 unknown_status NCT06304623
SVF for Treating Pulmonary Fibrosis Post COVID-19 No drug interventions treatment 1 completed NCT03267108
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension treatment 3 terminated NCT05747508
A Study to Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis treatment 2 unknown_status NCT05719038
Diagnostic and Prognostic Model of Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study No drug interventions Not Available Not Available not_yet_recruiting NCT00439543
Trial of Iloprost in Pulmonary Hypertension Secondary to Pulmonary Fibrosis treatment 2 / 3 unknown_status NCT04948203
Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis prevention 2 / 3 recruiting NCT05711290
Oxygen Nanobubble Drink Impact on Exercise in Pulmonary Fibrosis No drug interventions treatment Not Available completed NCT00070590
Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma treatment 2 / 3 completed NCT01335464
Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients treatment 3 completed NCT05365802
FAPI PET for Lung Fibrosis diagnostic 0 recruiting NCT00001884
Specimen Collection for Individuals With Lung Disease Associated With Rheumatoid Arthritis No drug interventions Not Available Not Available completed NCT06162884
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis No drug interventions Not Available Not Available not_yet_recruiting NCT02771184
Computerized Lung Sound Analysis No drug interventions basic_science Not Available completed NCT04979884
Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital treatment 3 completed NCT05121779
Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CT diagnostic 1 unknown_status NCT05670587
A Study in People With Pulmonary Fibrosis to Monitor Cough With a Wearable Device No drug interventions other Not Available completed NCT06251687
Application of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis No drug interventions diagnostic Not Available not_yet_recruiting NCT03727451
A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis No drug interventions treatment 2 completed NCT01916577
Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation treatment 1 completed NCT00981747
Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis treatment 2 / 3 terminated NCT00075998
The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF) treatment 3 terminated NCT02748798
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders diagnostic 0 recruiting NCT00514683
Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis treatment 2 completed NCT02852928
European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank No drug interventions Not Available Not Available recruiting NCT04987528
Pulmonary Fibrosis During Severe COVID-19 Pneumonia No drug interventions Not Available Not Available active_not_recruiting NCT02439528
Genetics of the Combined Pulmonary Fibrosis and Emphysema Syndrome No drug interventions other Not Available unknown_status NCT05899556
Pinpointing the Factors Affecting Clinical Study Experiences of Pulmonary Fibrosis Patients No drug interventions Not Available Not Available not_yet_recruiting NCT03567785
Supporting Adherence to Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT00001885
Identification of Genes Associated With Lung Disease in Patients With Rheumatoid Arthritis No drug interventions Not Available Not Available completed NCT04119115
Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases No drug interventions Not Available Not Available terminated NCT02510937
Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis treatment 1 completed NCT00001532
Role of Genetic Factors in the Development of Lung Disease No drug interventions Not Available Not Available recruiting NCT05635032
Fibrosing ILD Biomarkers That Rule Acceleration No drug interventions Not Available Not Available recruiting NCT06124859
Exercise Tolerance and Lower-limb Muscle Power in Patients With Chronic Respiratory Disease No drug interventions diagnostic Not Available not_yet_recruiting NCT02594059
Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis No drug interventions basic_science Not Available completed NCT04813575
COVID-19 Pathophysiology of Long Term Implications No drug interventions diagnostic Not Available unknown_status NCT05740475
A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects No drug interventions treatment 1 recruiting NCT00258570
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF) No drug interventions Not Available Not Available recruiting NCT01271842
Long-term Outcome and Lung Capacity in Survivors of ARDS Due to Influenza A (H1N1) v2009 The RESPIFLU Study No drug interventions Not Available Not Available completed NCT01241942
Phase 2 Study of Ex-vivo Perfusion and Ventilation of Lungs to Assess Transplant Suitability No drug interventions device_feasibility Not Available terminated NCT01135199
Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis treatment 2 withdrawn NCT04987606
Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions No drug interventions Not Available Not Available completed NCT03542318
Effects of Pulmonary Rehabilitation on Functional and Health Status Measures in Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT00005317
Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases No drug interventions Not Available Not Available completed NCT00000596
Diffuse Fibrotic Lung Disease treatment 2 completed NCT00001596
Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome treatment 2 completed NCT00004563
Scleroderma Lung Disease prevention 3 completed NCT03455686
Exploring the Utility of Hyperpolarized 129Xe MRI in Healthy Volunteers and Patients With Lung Disease No drug interventions basic_science Not Available recruiting NCT00052039
A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone treatment 3 terminated NCT02055222
Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease No drug interventions Not Available Not Available completed NCT04537130
Vaccination of Ex-acute COVID-19 Patients With Fibrosing Lung Syndrome at Discharge No drug interventions treatment 1 unknown_status NCT03056066
Accuracy of Spircare Device as Compared to the Conventional Plethysmograph No drug interventions Not Available Not Available unknown_status NCT01170065
Roll Over Study From 1199.30 BIBF 1120 in Idiopathic Pulmonary Fibrosis (IPF) treatment 2 completed NCT04767074
A Non-pharmacological Cough Control Therapy No drug interventions treatment Not Available recruiting NCT01417520
Clinical and Pathophysiological Investigations Into Erdheim Chester Disease No drug interventions Not Available Not Available completed NCT00611182
Dyspnea in Patients With Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT00352482
Sildenafil to Increase Exercise Capacity in Individuals With Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension treatment 2 completed NCT02496182
Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment treatment 2 / 3 unknown_status NCT00467831
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome treatment 1 / 2 terminated NCT05890573
Efficacy of Bailing Capsule on Pulmonary Fibrosis After COVID-19 No drug interventions treatment Not Available recruiting NCT00016627
Linkage Study in Familial Pulmonary Fibrosis No drug interventions Not Available Not Available completed NCT06327360
Illness Expectations in Pulmonary Fibrosis No drug interventions Not Available Not Available enrolling_by_invitation NCT00911794
Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease No drug interventions treatment Not Available completed NCT03103191
Diagnostic Value of KL-6 in ILD No drug interventions Not Available Not Available unknown_status NCT04170062
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest No drug interventions treatment Not Available recruiting NCT04488562
Home Monitoring and Evaluation After Admission for COVID-19 in the Netherlands No drug interventions Not Available Not Available completed NCT04619680
The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19 treatment 4 completed NCT00258544
Microarray Analysis of Gene Expression in Idiopathic Pulmonary Fibrosis (IPF) No drug interventions Not Available Not Available active_not_recruiting NCT05771740
Pulmonary Fibrosis Lung Sounds Study No drug interventions Not Available Not Available not_yet_recruiting NCT01121367
Study on Phenotypic Characterization of Combined Pulmonary Fibrosis and Emphysema No drug interventions Not Available Not Available completed NCT00455767
Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients No drug interventions treatment 2 completed NCT00457301
Using Health-related Quality of Life (HRQL) in Routine Clinical Care No drug interventions Not Available Not Available completed NCT03385668
Pilot Study of Pirfenidone in Pulmonary Fibrosis With Anti-myeloperoxydase Antibodies treatment 2 completed NCT06457269
Evaluating the Potential of Large Language Models for Respiratory Disease Consultations No drug interventions diagnostic Not Available completed NCT00063869
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis treatment 2 completed NCT01687946
Explorative Study on the Molecular Pathology of Lung Fibrosis by Combination of Clinical Assessment and System Biology No drug interventions Not Available Not Available completed NCT00563212
A Pilot Study of Aerosol Interferon-gamma for Treatment of Idiopathic Pulmonary Fibrosis treatment 1 completed NCT00109681
Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis treatment 2 completed NCT06275295
A Retrospective Study of Transbronchial Cryobiopsy in the Diagnosis of Progressive Pulmonary Fibrosis No drug interventions Not Available Not Available not_yet_recruiting NCT04136223
Rheumatoid Arthritis-Associated Interstitial Lung Disease: Characterization of Lung Disease Progression No drug interventions Not Available Not Available active_not_recruiting NCT00080223
Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis other 2 completed NCT01825538
Assessment of Pulmonary Specialty Physicians' Approach to Advanced Care Planning in Patients With Chronic Pulmonary Diseases No drug interventions Not Available Not Available completed NCT01203943
A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) treatment 2 terminated